Knockdown of UBD Ameliorates Experimental Rheumatoid Arthritis by Suppressing TLR4/Myd88/NF-κB and P38/MAPK Pathway
Cellular Physiology and Biochemistry · 01.09.2025 · 59 (5) · 557-568
DOI: 10.33594/000000808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Physiology and Biochemistry, online erschienen am 01.09.2025. Verfasst von Hong Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Arthritis, Rheumatoid, Arthritis, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Background/Aims: Ubiquitin D (UBD), a member of the ubiquitin-like modifier (UBL) family, is significantly overexpressed in various cancers and is positively correlated with tumor progression. However, the role and underlying mechanisms of UBD in rheumatoid arthritis (RA) remain poorly understood. This study aimed to investigate the effects of UBD knockdown on the progression of RA. Materials: We employed the type II collagen and incomplete Freund’s adjuvant (CIA) rat model. A variety of analytical techniques were employed, including hematoxylin and eosin (H&E) staining, Safranin O and Fast Green staining, tartrate-resistant acid phosphatase (TRAP) staining, enzyme-linked immunosorbent assay (ELISA), and Western blot analysis, to elucidate the mechanisms involved.
Results
UBD knockdown correlated with diminished cartilage and bone erosion, reduced counts of TRAP-positive osteoclasts, and enhanced Safranin O staining of the cartilage. Additionally, the knockdown significantly reduced serum levels of PGE2, TNF-α, TIMP-1, IL-1β, MMP-9, and IL-6 in CIA rats. Furthermore, UBD knockdown markedly suppressed the expression levels of phosphorylated p38, TLR4, MyD88, and phosphorylated p65, suggesting a critical role in modulating inflammatory signaling pathways in RA.
Conclusion
Collectively, these results suggested that knockdown of UBD significantly alleviated arthritis progression in the CIA rat model, highlighting UBD as a potential therapeutic target and a promising prognostic biomarker for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
- Department of Preclinica Sciences, Faculty of Dentistry, MAHSA University, Bandar Saujana Putra, Jeniarom, Selangor, Malaysia.
- Department of Preclinica Sciences, Faculty of Dentistry, MAHSA University, Bandar Saujana Putra, Jeniarom, Selangor, Malaysia, E-Mail: Djooi@mahsa.edu.my.
- Department of General Practice, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China, E-Mail: weihch123456@163.com.
Zitieren
APA
Chen, H., Liu, S., Zhang, Y., Jun, O., & Wei, H. (2025). Knockdown of UBD Ameliorates Experimental Rheumatoid Arthritis by Suppressing TLR4/Myd88/NF-κB and P38/MAPK Pathway. Cellular Physiology and Biochemistry, 59(5), 557-568. https://doi.org/10.33594/000000808
Vancouver
Chen H, Liu S, Zhang Y, Jun O, Wei H. Knockdown of UBD Ameliorates Experimental Rheumatoid Arthritis by Suppressing TLR4/Myd88/NF-κB and P38/MAPK Pathway. Cellular Physiology and Biochemistry. 2025;59(5):557-568. doi:10.33594/000000808
BibTeX
@article{Chen2025,
author = {Chen, Hong and Liu, Sha and Zhang, Yu and Jun, Ooi Der and Wei, Hua},
title = {Knockdown of UBD Ameliorates Experimental Rheumatoid Arthritis by Suppressing TLR4/Myd88/NF-κB and P38/MAPK Pathway},
journal = {Cellular Physiology and Biochemistry},
year = {2025},
volume = {59},
number = {5},
pages = {557--568},
doi = {10.33594/000000808}
}
EUVIMED